TRVI position history
The shares of Trevi Therapeutics (TRVI) that Avidity Partners Management LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q1: 13,320 shares, $171K, 0.02% of portfolio, New
- 2026 Q2: 6,660 shares, $124K, 0.02% of portfolio, Reduce −50.0%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|